Low Dose Naltrexone

A next-generation, non-opioid treatment, LDN is a biphasic pill with immediate shell release that targets inflammation and pain pathways to potentially provide lasting relief without addiction risks.

Highlights

Entering Pivotal Studies with FDA orphan drug designation

Reduces chronic inflammation and potentially rewires pain perception

Completed several clinical trials with strong safety data

How it Works

How it Works

LDN works through a unique mechanism of action targeting pain and inflammation pathways:

  • Acts on Toll-Like Receptors (TLR) to modulate pain perception
  • Increases endorphins, the body's natural painkillers
  • Reduces microglial cell activity, which plays a role in chronic pain
  • Decreases interleukin activity, lowering nerve inflammation
Related Solution

Low Dose Naltrexone

A novel, non-opioid drug with transformative potential, LDN has completed multiple clinical trials and is progressing toward regulatory approval as an Orphan Drug. Non-opioid pain medication is the Holy Grail of pharma, and LDN stands at the forefront of this movement.

Learn More